Prostamax
Peptide Bioregulator
Also known as Lys-Glu-Asp-Pro (KEDP)
Prostamax is a short synthetic peptide of the bioregulator class, supplied as the tetrapeptide Lys-Glu-Asp-Pro and associated in research with prostate tissue models.
Mix & Match
1 vial — no vial discount yet.
Add 2 more vials for 5% off.
After that, 10% at 5 vials, 20% at 10 vials.
This product is intended strictly for laboratory research use within the United States. It is not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable U.S. federal, state, and local regulations.
Prostamax is a short synthetic peptide of the bioregulator class, supplied as the tetrapeptide Lys-Glu-Asp-Pro and associated in research with prostate tissue models.
Published work on this specific sequence is limited; most available research addresses the short-peptide class collectively.
Third-party tested for purity, ID, quantity.
Coming Soon
The certificate of analysis for the 20mg lot is being finalised and will be published here as soon as the lab returns it.
Prostamax sits within the family of tissue-directed short peptides investigated in organotypic tissue culture. Available research examined tissue-specific effects of synthetic peptide bioregulators in cultures taken from young and old rats, and the broader role of short peptides in cell differentiation.
The compound-specific literature is thin. Researchers should treat the class-level literature as background rather than as evidence about this sequence in isolation.
Prostamax arises from the Russian peptide-bioregulator programme, which paired tissue extracts with defined synthetic short-peptide analogues intended to reproduce their activity.
Published investigation has remained largely confined to organotypic culture studies.
Research relevant to Prostamax centers on tissue-specific short-peptide activity in organotypic culture and on peptide regulation of cell differentiation. Reference support is thin relative to better-characterized compounds.
4 of the 4 areas below are addressed directly by a paper cited on this page.
Organotypic tissue-culture models
Addressed on this page by Zakutskiĭ 2006. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Zakutskiĭ, AN. et al. (2006) — The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats
Tissue-directed bioregulator research
Addressed on this page by Zakutskiĭ 2006. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Zakutskiĭ, AN. et al. (2006) — The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats
Peptide-regulated cell differentiation
Addressed on this page by Khavinson 2020, Zakutskiĭ 2006. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Khavinson, V. et al. (2020) — Peptide Regulation of Cell Differentiation
- Zakutskiĭ, AN. et al. (2006) — The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats
Age-comparative culture studies
Addressed on this page by Zakutskiĭ 2006. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Zakutskiĭ, AN. et al. (2006) — The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats
The references section of this page cites 2 primary papers published between 2006 and 2020 — a thin record. Every citation is linked to its PubMed or DOI record so it can be read rather than taken on trust, and the summaries above describe what those papers report rather than what the compound is claimed to do.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for Prostamax, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
Prostamax is commonly described online in connection with faster healing from injury and improved recovery. In the research literature the same compound is filed under organotypic tissue-culture models, tissue-directed bioregulator research and peptide-regulated cell differentiation.
The 2 papers cited on this page, published between 2006 and 2020 (1 in animal models) describe laboratory and animal work. None reports a controlled trial in humans. Findings in cell culture or in a rodent model describe what happened in that system; they do not establish that the same occurs in humans, and this compound is not approved for human use.
Presented alongside compounds with decades of published research, as though the evidence base is comparable.
It is not. Prostamax rests on 2 cited papers (between 2006 and 2020). A record that thin cannot support conclusions about mechanism, effect or safety, and the honest reading is that this compound has been studied very little rather than studied and validated.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
Every lot of Prostamax is independently assayed before it is released, and the certificate for the lot shipped is published rather than summarised. Where a certificate for a current lot is not yet posted, the lot has not yet been released against it.
Researchers who buy Prostamax in the United States through Eppix Labs receive a batch-labelled vial whose certificate is published against that lot code, so the material can be matched to its analysis rather than to a generic specification.
- Lyophilized storage
- −20 °C long-term; stable at room temperature in transit
- After reconstitution
- 2–8 °C
- Light
- Protect from UV and direct light
- Freeze-thaw
- Avoid repeated cycles
- Vehicle
- Bacteriostatic water in most published protocols
- Format
- Lyophilized powder
Prostamax is supplied as lyophilized powder. In the dry state the material is comparatively stable, which is why it ships at ambient temperature without a cold chain; once reconstituted it is a peptide in solution and the handling constraints tighten considerably. At 4 residues it is short enough to be produced by solid-phase synthesis, and the published sequence on this page is what an identity assay is checked against.
Repeated freeze-thaw cycling is the handling error most likely to degrade material of this class, because each cycle concentrates solutes at the ice boundary. Where a protocol calls for the same vial across multiple sessions, the published literature generally describes aliquoting after reconstitution rather than re-freezing the whole volume.
Vials may appear empty on arrival. Lyophilized material collects at the base of the vial and is often not visible until the vial is inspected under direct light.
- 1 × sealed glass vial in the strength selected (20mg / Single Vial, 20mg / 5-Pack, 20mg / 10-Pack available), batch-labelled
- Batch documentation for the lot shipped, once its certificate is published
- Discreet outer packaging with no product names on the exterior
- FedEx, tracked, typically 1–3 business days domestically
- Bacteriostatic water or any other reconstitution vehicle
- Syringes, needles or filters
- Dosing, administration or protocol guidance of any kind
Reconstitution materials are sourced separately. The reconstitution calculator on this site works out concentrations for a given volume, but it is an arithmetic tool for laboratory record-keeping and not a protocol.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of Prostamax. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
Related
You May Also Like
Next-generation GLP receptor agonist studied for metabolic signaling and nutrient partitioning pathways
From$79.99
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$39.99
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$59.99
Long-acting amylin analog engineered for appetite signaling, metabolic control, and energy balance research
From$99.99